SCHEMBL1132013

SCHEMBL1132013

CCOC(=O)/C(C)=C/c1cc(C2CCCCC2)n(-c2ccc(O)cc2)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.37
ALDH1A1 P00352 4/20 0.37
KMT2A Q03164 4/20 0.37
KDM4E B2RXH2 2/20 0.37
HPGD P15428 1/20 0.37
NPY1R P25929 1/20 0.37
NPY2R P49146 1/20 0.37
EPHX2 P34913 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
FAAH O00519 4/20 0.36
NPSR1 Q6W5P4 3/20 0.36
SLC5A1 P13866 4/20 0.36
LMNA P02545 2/20 0.36
MAPT P10636 2/20 0.36
GAA P10253 1/20 0.36
RAB9A P51151 3/20 0.35
NPC1 O15118 2/20 0.35
XBP1 P17861 2/20 0.35
S1PR2 O95136 1/20 0.35
NR2F2 P24468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1132015 1.00 MEN1 (0.37) MEN1ALDH1A1KMT2AKDM4EHPGD
SCHEMBL12860131 0.88 FAAH (0.37) ALDH1A1HPGDEPHX2SMN1; SMN2FAAH
SCHEMBL1131659 0.86 PTPN1 (0.47) ALDH1A1SMN1; SMN2MAPTRAB9ANPC1
SCHEMBL1132051 0.86 PTPN1 (0.47) ALDH1A1SMN1; SMN2MAPTRAB9ANPC1
SCHEMBL1131260 0.85 SLC5A1 (0.39) EPHX2SLC5A1
SCHEMBL1131557 0.79 FAAH (0.40) MEN1ALDH1A1KMT2AKDM4EHPGD
SCHEMBL1131559 0.79 FAAH (0.40) MEN1ALDH1A1KMT2AKDM4EHPGD
SCHEMBL1132020 0.77 PTGS2 (0.42) ALDH1A1FAAHMAPK1
SCHEMBL1132017 0.77 PTGS2 (0.42) ALDH1A1FAAHMAPK1
SCHEMBL12860128 0.76 FAAH (0.39) MEN1ALDH1A1KMT2AKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1663105-B1 CYCLOALKYL HETEROCYCLES FOR TREATING HEPATITIS C VIRUS BRISTOL MYERS SQUIBB CO (US) 2011-02-16 EP disclosed
EP-1663105-B1 CYCLOALKYL HETEROCYCLES FOR TREATING HEPATITIS C VIRUS BRISTOL MYERS SQUIBB CO (US) 2011-02-16 EP disclosed